Sylvain Arnould

Title: Sylvain Arnould: Innovator in Genome Engineering

Introduction

Sylvain Arnould is a prominent inventor based in Paris, France. He has made significant contributions to the field of genome engineering, particularly through his work with meganucleases. With a total of five patents to his name, Arnould's innovations are paving the way for advancements in gene therapy and genetic research.

Latest Patents

Arnould's latest patents include groundbreaking methods for using meganucleases to induce homologous recombination in vertebrate somatic tissues. One notable patent focuses on the use of meganucleases for cleaving DNA in non-human or isolated human cells, which can lead to applications in genome engineering and gene therapy. Another patent details a monomer of an I-CreI meganuclease variant that includes specific mutations in its amino acid sequence, enhancing its ability to bind and cleave DNA target sequences.

Career Highlights

Throughout his career, Sylvain Arnould has worked with notable companies such as Cellectis S.A. and Cellectis. His expertise in the field has allowed him to develop innovative solutions that address complex challenges in genetic engineering.

Collaborations

Arnould has collaborated with esteemed colleagues, including Patrick Chames and Jean-Charles Epinat. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Sylvain Arnould's work in genome engineering exemplifies the impact of innovative thinking in the field of genetics. His patents and collaborations continue to influence advancements in gene therapy and genetic research.